Pre-treatment risk predictors of valproic acid-induced dyslipidemia in pediatric patients with epilepsy

• Main Authors: Tiantian Liang (Author), Chenquan Lin (Author), Hong Ning (Author), Fuli Qin (Author), Bikui Zhang (Author), Yichang Zhao (Author), Ting Cao (Author), Shimeng Jiao (Author), Hui Chen (Author), Yifang He (Author), Hualin Cai (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Valproic acid (VPA) stands as one of the most frequently prescribed medications in children with newly diagnosed epilepsy. Despite its infrequent adverse effects within therapeutic range, prolonged VPA usage may result in metabolic disturbances including insulin resistance and dyslipidem...